Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29046

1.

A survival analysis comparing women with ovarian low-grade serous carcinoma to those with high-grade histology.

Chen M, Jin Y, Bi Y, Yin J, Wang Y, Pan L.

Onco Targets Ther. 2014 Oct 16;7:1891-9. doi: 10.2147/OTT.S67812. eCollection 2014.

PMID:
25342912
[PubMed]
2.

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Uterine Serous Carcinoma.

Sagae S, Susumu N, Viswanathan AN, Aoki D, Backes FJ, Provencher DM, Vaughan M, Creutzberg CL, Kurzeder C, Kristensen G, Lee C, Kurtz JE, Glasspool RM, Small W Jr.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S83-S89.

PMID:
25341586
[PubMed - as supplied by publisher]
3.

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary.

Okamoto A, Glasspool RM, Mabuchi S, Matsumura N, Nomura H, Itamochi H, Takano M, Takano T, Susumu N, Aoki D, Konishi I, Covens A, Ledermann J, Mezzazanica D, Steer C, Millan D, McNeish IA, Pfisterer J, Kang S, Gladieff L, Bryce J, Oza A.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S20-S25.

PMID:
25341576
[PubMed - as supplied by publisher]
4.

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Mucinous Ovarian Carcinoma.

Ledermann JA, Luvero D, Shafer A, O'Connor D, Mangili G, Friedlander M, Pfisterer J, Mirza MR, Kim JW, Alexandre J, Oza A, Brown J.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S14-S19.

PMID:
25341574
[PubMed - as supplied by publisher]
5.

Alterations in the serum proteome profile during the development of ovarian cancer.

Sun L, Li L, Li Z, Hong S, Yang Q, Qu X, Kong B.

Int J Oncol. 2014 Sep 25. doi: 10.3892/ijo.2014.2675. [Epub ahead of print]

PMID:
25340615
[PubMed - as supplied by publisher]
6.

HER2 Expression in Ovarian Mucinous Carcinomas in Tunisia.

Missaoui N, Abdelkarim SB, Ayachi M, Hmissa S, Yaacoubi MT.

Asian Pac J Cancer Prev. 2014;15(19):8121-5.

PMID:
25338994
[PubMed - in process]
Free Article
7.

Up-regulation of miR-335 predicts a favorable prognosis in esophageal squamous cell carcinoma.

Zhang BJ, Gong HY, Zheng F, Liu DJ, Liu HX.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6213-8. eCollection 2014.

PMID:
25337272
[PubMed - in process]
Free PMC Article
8.

Gold(I) complexes of 9-deazahypoxanthine as selective antitumor and anti-inflammatory agents.

Vančo J, Gáliková J, Hošek J, Dvořák Z, Paráková L, Trávníček Z.

PLoS One. 2014 Oct 15;9(10):e109901. doi: 10.1371/journal.pone.0109901. eCollection 2014.

PMID:
25333949
[PubMed - in process]
Free PMC Article
9.

Smad7 maintains epithelial phenotype of ovarian cancer stem‑like cells and supports tumor colonization by mesenchymal‑epithelial transition.

Li Y, Gong W, Ma X, Sun X, Jiang H, Chen T.

Mol Med Rep. 2014 Oct 21. doi: 10.3892/mmr.2014.2714. [Epub ahead of print]

PMID:
25333457
[PubMed - as supplied by publisher]
10.

miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma.

Dong R, Liu X, Zhang Q, Jiang Z, Li Y, Wei Y, Li Y, Yang Q, Liu J, Wei JJ, Shao C, Liu Z, Kong B.

Oncotarget. 2014 Oct 14. [Epub ahead of print]

PMID:
25333261
[PubMed - as supplied by publisher]
Free Article
11.

RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis.

Guo C, Ren F, Wang D, Li Y, Liu K, Liu S, Chen P.

Oncol Rep. 2014 Dec;32(6):2580-8. doi: 10.3892/or.2014.3524. Epub 2014 Oct 3.

PMID:
25333219
[PubMed - in process]
12.

Impact of adjuvant chemotherapy for stage I ovarian carcinoma with intraoperative tumor capsule rupture.

Shimizu D, Sato N, Sato T, Makino K, Kito M, Shirasawa H, Kumagai J, Terada Y.

J Obstet Gynaecol Res. 2014 Oct 20. doi: 10.1111/jog.12551. [Epub ahead of print]

PMID:
25330897
[PubMed - as supplied by publisher]
13.

Precursors of ovarian cancer in the fallopian tube: Serous tubal intraepithelial carcinoma - an update.

Zeppernick F, Meinhold-Heerlein I, Shih IM.

J Obstet Gynaecol Res. 2014 Oct 20. doi: 10.1111/jog.12550. [Epub ahead of print]

PMID:
25330822
[PubMed - as supplied by publisher]
14.

Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity.

Yasuda K, Torigoe T, Mariya T, Asano T, Kuroda T, Matsuzaki J, Ikeda K, Yamauchi M, Emori M, Asanuma H, Hasegawa T, Saito T, Hirohashi Y, Sato N.

Lab Invest. 2014 Oct 20. doi: 10.1038/labinvest.2014.122. [Epub ahead of print]

PMID:
25329002
[PubMed - as supplied by publisher]
15.

[Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer].

Tang X, Lu M, Li C, Deng S, Li M.

Zhonghua Fu Chan Ke Za Zhi. 2014 Jul;49(7):517-22. Chinese.

PMID:
25327734
[PubMed - in process]
16.

[Characteristics change of the human directional highly lymphatic metastasis ovarian carcinoma cell and venous endothelial cell after establishment of their condition cultrue and co-culture cell system].

Lu Y, Gao T, Chen Y, Zhang X, Li L, Xie Y, Li H, Ruan H, Li D.

Zhonghua Fu Chan Ke Za Zhi. 2014 Jul;49(7):510-6. Chinese.

PMID:
25327733
[PubMed - in process]
17.

ATP-Based Chemotherapy Response Assay in Primary or Recurrent Ovarian and Peritoneal Cancer.

Lee M, Kim SW, Nam EJ, Cho H, Kim JH, Kim YT, Kim S.

Yonsei Med J. 2014 Nov 1;55(6):1664-71. doi: 10.3349/ymj.2014.55.6.1664.

PMID:
25323906
[PubMed - in process]
Free Article
18.

DNA hypomethylation-mediated overexpression of carbonic anhydrase 9 induces an aggressive phenotype in ovarian cancer cells.

Sung HY, Ju W, Ahn JH.

Yonsei Med J. 2014 Nov 1;55(6):1656-63. doi: 10.3349/ymj.2014.55.6.1656.

PMID:
25323905
[PubMed - in process]
Free Article
19.

Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells.

Bao L, Jaramillo MC, Zhang Z, Zheng Y, Yao M, Zhang DD, Yi X.

Mol Med Rep. 2014 Oct 16. doi: 10.3892/mmr.2014.2671. [Epub ahead of print]

PMID:
25322694
[PubMed - as supplied by publisher]
20.

CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells.

Gil M, Komorowski MP, Seshadri M, Rokita H, McGray AJ, Opyrchal M, Odunsi KO, Kozbor D.

J Immunol. 2014 Oct 15. pii: 1400201. [Epub ahead of print]

PMID:
25320277
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk